Puffy hands and fingers, as well as other symptoms, can precede the “warning sign” of Raynaud’s syndrome as the initial ...

New 3D tissue model offers a breakthrough tool for understanding and treating scleroderma and other fibrotic diseases.

There is a subset of scleroderma patients who have a condition called diffuse cutaneous systemic sclerosis, which often has a worse prognosis. Now, scientists have identified a potential biomarker of ...

The auto-immune condition Scleroderma affects hundreds of thousands of men, women, and children, yet very few people know about the diagnosis. Monika Hilton and Kimberly Gonzalez were diagnosed ...

The University of Michigan John Varga Lab, in collaboration with the Mayo Clinic and Northwestern researchers, published an article last year suggesting that a heavy-chain monoclonal antibody, Ab68, ...

Cyclophosphamide as Disease-modifying Therapy for Scleroderma Cecilia Chighizola; Voon H Ong; Christopher P Denton Disclosures Int J Clin Rheumatol. 2011;6 (2):219-230. 0 ...

The mean frequency of internal organ involvement in patients with ssSSc was 46% for interstitial lung disease, 15% for pulmonary arterial hypertension, 5% for scleroderma renal crisis, and 26.5% ...

Scleroderma affects approximately 300,000 people in the U.S., with about one-third developing systemic disease, which can affect major organs such as the lungs, kidneys or heart.